ADAG Stock Surges Amidst Biotech Sector Growth
| BTTXDelisted Stock | USD 0.73 0.04 5.19% |
Slightly above 62% of Better Therapeutics' investor base is looking to short. The analysis of the overall prospects from investing in Better Therapeutics suggests that many traders are, at the present time, alarmed. Better Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Better Therapeutics' earnings reports, geopolitical events, and overall market trends.
Better |
Tianyan Pharmaceuticals , a clinical-stage biopharmaceutical company, saw its stock price rise by 6.08. The stock is currently trading at 2.36 per share
Read at gurufocus.com
 |
Better Therapeutics Fundamental Analysis
We analyze Better Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Better Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Better Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Better Therapeutics is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Better Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Better Therapeutics otc stock to make a market-neutral strategy. Peer analysis of Better Therapeutics could also be used in its relative valuation, which is a method of valuing Better Therapeutics by comparing valuation metrics with similar companies.
Peers
Better Therapeutics Related Equities
| ADAG | Adagene | 25.25 | ||||
| INZY | Inozyme Pharma | 9.56 | ||||
| ANTX | AN2 Therapeutics | 6.34 | ||||
| TERN | Terns Pharmaceuticals | 5.17 | ||||
| ACRV | Acrivon Therapeutics, | 3.16 | ||||
| CING | Cingulate | 1.17 | ||||
| ABVC | ABVC Biopharma | 1.06 | ||||
| ANEB | Anebulo Pharmaceuticals | 0.64 | ||||
| PMVP | Pmv Pharmaceuticals | 0.63 | ||||
| IKT | Inhibikase Therapeutics | 0.31 | ||||
| RZLT | Rezolute | 1.39 | ||||
| DAWN | Day One | 1.86 | ||||
| AVTE | Aerovate Therapeutics | 2.23 | ||||
| ABOS | Acumen Pharmaceuticals | 3.56 | ||||
| KTTA | Pasithea Therapeutics | 3.61 | ||||
| INDP | Indaptus Therapeutics | 3.85 | ||||
| HOOK | Hookipa Pharma | 5.12 | ||||
| FBRX | Forte Biosciences | 7.59 | ||||
| SNTI | Senti Biosciences | 13.80 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Better OTC Stock
If you are still planning to invest in Better Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Better Therapeutics' history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |